Key result
Increasing age was significantly correlated with worsening metabolic profiles, with elevated total cholesterol and body mass index exceeding reference values starting in individuals aged 30 and older.
Why the study?
Population biobanks are essential for developing public health screening and advancing personalized medicine, prompting an evaluation of cardiovascular risk and metabolic profiles among regional inhabitants.
Cross-Sectional (n=2,274)
Answers are grounded in this paper and cite their sources.
Metabolic and biochemical changes predisposing to cardiovascular disease are evident in individuals as young as 30 years old, suggesting a need for earlier CVD screening programs.
Introduction: Population biobanks are essential for the development of public health screening and improvement of personalized medicine. Since 2012, Biobank of Łukasiewicz Research Network - PORT Polish Center for Technology Development (PORT Biobank) has collected more than 120 000 biological samples from nearly 5000 inhabitants of Lower Silesia, together with a variety of demographic, anthropometric, life style and health information. Material and methods: The analyzed group consisted of 2274 participants (1398 women, 876 men). Both women and men were further subdivided into five age decades (20+, 30+, 40+, 50+, 60+). For this study, the level of lipids (total cholesterol, high-density lipoprotein (HDL), low-density lipoprotein (LDL), triglycerides) was estimated and correlated with the level of high-sensitivity C-reactive protein (hs-CRP) and biometric parameters. Results: We have demonstrated for the first time that biochemical changes that may lead to cardiovascular diseases (CVD) occurred already in the group of people aged 30+. Our observation is based on measurements of lipids, glucose, inflammatory (hs-CRP) and biometric markers such as body mass index (BMI) and waist-to-hip ratio (WHR). Conclusions: Positive correlations with age for these variables suggest the ongoing progress of metabolic changes, which in the end may lead to a fatal outcome such as myocardial infarction or stroke. It suggests that CVD screening programs should be dedicated to a wider group, especially younger citizens, in order to prevent fatal outcomes related to CVD.
No takes yet. Share an insight, caveat, or question.
Kozera et al. (2020) conducted a cross-sectional in Cardiovascular risk (n=2,274). Increasing age vs. Younger age group (20-29 years) was evaluated on Correlation between age and metabolic/biometric parameters (total cholesterol, LDL-C, BMI, hs-CRP) (p=<0.0001). Increasing age was significantly correlated with worsening metabolic profiles, with elevated total cholesterol and body mass index exceeding reference values starting in individuals aged 30 and older.
Synapse has enriched 10 related papers. Consider them for comparative context: